LifeMD delays third-quarter report to correct accounting errors
LFMD•LifeMD delayed its third-quarter Form 10-Q beyond the November 9 deadline and expects to file within five calendar days. It is correcting overstated revenue and understated expenses in financial statements from 2024 through June 30, 2026; the corrections will not affect cash flow or cash position.
1. Filing delay
LifeMD delayed its Form 10-Q for the quarter ended September 30, 2026, beyond the November 9, 2026, deadline. The company expects to file within five calendar days of the original deadline.
2. Accounting corrections
The additional time is needed to correct overstated revenue and understated expenses in quarterly and annual financial statements from 2024 through June 30, 2026. The corrections will not affect cash flow or cash position. Management is evaluating the potential impact on disclosure controls and internal control over financial reporting.
